V023-7839 Screening compound: N-[(4-fluorophenyl)methyl]-N-(2-{4-[6-(4-methoxyphenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)cyclopropanecarboxamide

V023-7839 Screening compound: N-[(4-fluorophenyl)methyl]-N-(2-{4-[6-(4-methoxyphenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)cyclopropanecarboxamide
V023-7839 Screening compound: N-[(4-fluorophenyl)methyl]-N-(2-{4-[6-(4-methoxyphenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)cyclopropanecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V023-7839
N-[(4-fluorophenyl)methyl]-N-(2-{4-[6-(4-methoxyphenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)cyclopropanecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V023-7839

Molecular Formula

C29H32FN5O3 (C29 H32 FN5 O3)

Compound Name

N-[(4-fluorophenyl)methyl]-N-(2-{4-[6-(4-methoxyphenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)cyclopropanecarboxamide

IUPAC name

N-[(4-fluorophenyl)methyl]-N-(2-{4-[6-(4-methoxyphenyl)pyridazin-3-yl]-14-diazepan-1-yl}-2-oxoethyl)cyclopropanecarboxamide

SMILES

COc(cc1)ccc1-c(cc1)nnc1N(CCC1)CCN1C(CN(Cc(cc1)ccc1F)C(C1CC1)=O)=O

InChI

InChI=1S/C29H32FN5O3/c1-38-25-11-7-22(8-12-25)26-13-14-27(32-31-26)33-15-2-16-34(18-17-33)28(36)20-35(29(37)23-5-6-23)19-21-3-9-24(30)10-4-21/h3-4,7-14,23H,2,5-6,15-20H2,1H3

InChI Key

ZHBOQBSFJRGJJF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19834778

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

517.6

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.757

Distribution Coefficient, logD

3.753

Water Solubility, LogSw

-4.04

Polar Surface Area

65.164

Acid Dissociation Constant (pKa)

21.75

Base Dissociation Constant (pKb)

5.34

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

37.90

V023-7839 in Drug Discovery

Included in Screening Libraries

MCL1 Targeted Library (12200 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic

References: we are preparing a list of scientific research reports with V023-7839 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V023-7839?
Check Price and Availability of V023-7839, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V023-7839 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V023-7839
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V023-7839
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V023-7839 available by request